A multicentre randomised controlled trial of drug-eluting versus bare metal stents in the treatment of patients over 80 years of age with complex coronary artery disease

Trial Profile

A multicentre randomised controlled trial of drug-eluting versus bare metal stents in the treatment of patients over 80 years of age with complex coronary artery disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Oct 2014

At a glance

  • Drugs Everolimus (Primary)
  • Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms XIMA
  • Sponsors Abbott Vascular
  • Most Recent Events

    • 25 Oct 2014 United Kingdom Clinical Research Network reports accrual to date changed from 49% to 50%.
    • 06 Nov 2013 Results published in the Journal of the American College of Cardiology.
    • 11 Mar 2013 Primary endpoint results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top